Cargando…

Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML

Detalles Bibliográficos
Autores principales: Petersen, Christopher, Li, Jian-Ming, Waller, Edmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649410/
http://dx.doi.org/10.1186/2051-1426-3-S2-P238
_version_ 1782401352614281216
author Petersen, Christopher
Li, Jian-Ming
Waller, Edmund
author_facet Petersen, Christopher
Li, Jian-Ming
Waller, Edmund
author_sort Petersen, Christopher
collection PubMed
description
format Online
Article
Text
id pubmed-4649410
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46494102015-11-24 Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML Petersen, Christopher Li, Jian-Ming Waller, Edmund J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649410/ http://dx.doi.org/10.1186/2051-1426-3-S2-P238 Text en Copyright © 2015 Petersen et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Petersen, Christopher
Li, Jian-Ming
Waller, Edmund
Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
title Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
title_full Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
title_fullStr Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
title_full_unstemmed Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
title_short Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
title_sort administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia t cell response in a murine model of aml
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649410/
http://dx.doi.org/10.1186/2051-1426-3-S2-P238
work_keys_str_mv AT petersenchristopher administrationofavasoactiveintestinalpeptideantagonistsignificantlyenhancestheautologousantileukemiatcellresponseinamurinemodelofaml
AT lijianming administrationofavasoactiveintestinalpeptideantagonistsignificantlyenhancestheautologousantileukemiatcellresponseinamurinemodelofaml
AT walleredmund administrationofavasoactiveintestinalpeptideantagonistsignificantlyenhancestheautologousantileukemiatcellresponseinamurinemodelofaml